ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells

Tsuimin Tsai1, Hong Tai Ji, Pei-Chi Chiang

  • 1Graduate Institute of Biomedical Materials and Engineering, Graduate School of Dentistry, Taipei Medical University, Taipei 110, Taiwan.

Abstract

Insights

Photodynamic therapy using 5-aminolevulinic acid (ALA-PDT) reduces cancer cell invasion and epidermal growth factor receptor (EGFR) expression. These anti-metastatic effects in surviving cancer cells can be passed to their progeny.

Area of Science:

  • Oncology
  • Cell Biology
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) mechanisms are understood at cellular and tissue levels.
  • The behavior of cancer cells surviving PDT remains unclear.
  • Investigating post-PDT cellular changes is crucial for understanding treatment efficacy and metastasis.

Purpose of the Study:

  • To investigate the impact of 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) on the invasion capabilities of surviving cancer cells.
  • To analyze molecular alterations, specifically epidermal growth factor receptor (EGFR) expression, in cancer cells post-ALA-PDT.
  • To determine if these acquired traits are heritable by the progeny of surviving cancer cells.

Main Methods:

  • Human invasive carcinoma cell lines (lung, melanoma, breast) were subjected to ALA-PDT.
  • Surviving cells were cultured to establish PDT-derived variants.
  • Migration and invasion assays were performed.
  • Gene and protein expression of EGFR were analyzed using RT-PCR and immunoblotting.

Main Results:

  • ALA-PDT induced reduced migration in all surviving cancer cell types.
  • PDT-derived variants exhibited altered morphology, reduced mitochondrial function, and suppressed invasiveness compared to parental cells.
  • EGFR expression was downregulated in PDT-derived variants, correlating with reduced invasion.

Conclusions:

  • ALA-PDT not only kills cancer cells but also reduces their invasion potential and EGFR expression.
  • These anti-metastatic effects are heritable, passing to the progeny of surviving cells.
  • ALA-PDT presents a novel mechanism to potentially inhibit tumor metastasis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...